Smd Chemi-Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.25 M
- Company Age 26 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 31.33%
- Ebitda 73.75%
- Net Worth -3.13%
- Total Assets -0.32%
About Smd Chemi-Pharma
Smd Chemi-Pharma Private Limited (SCPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 November 1998 and has a history of 26 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.25 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Kumar and Daman Singhal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24117DL1998PTC096933
-
Company No.
096933
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Nov 1998
-
Date of AGM
18 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Smd Chemi-Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daman Singhal
|
Director | 24-Dec-2013 | Current |
|
Satish Kumar
|
Director | 05-Nov-1998 | Current |
Financial Performance of Smd Chemi-Pharma.
Smd Chemi-Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 31.33% increase in profit. The company's net worth dipped by a decrease of 3.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smd Chemi-Pharma?
Unlock access to Smd Chemi-Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Unispeed Pharmaceuticals Private LimitedSatish Kumar and Daman Singhal are mutual person
-
Baddi InfrastructureSatish Kumar is a mutual person
-
Quadriga Biotech Private LimitedSatish Kumar is a mutual person
-
Culmen Exim Private Limited
Satish Kumar is a mutual person
-
Himachal Pharma Testing Lab Limited
Satish Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Smd Chemi-Pharma?
Unlock and access historical data on people associated with Smd Chemi-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smd Chemi-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smd Chemi-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
